Novartis (Tekturna) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Novartis (Tekturna) General Information
Description
Rights to manufacture, market and sell Tekturna. It is a prescription medicine for adults to treat high blood pressure.
Contact Information
Website
www.tekturna.comCorporate Office
- One Health Plaza
- East Hanover, NJ 07936
- United States
Corporate Office
- One Health Plaza
- East Hanover, NJ 07936
- United States
Novartis (Tekturna) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Novartis (Tekturna) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Novartis (Tekturna) FAQs
-
Where is Novartis (Tekturna) headquartered?
Novartis (Tekturna) is headquartered in East Hanover, NJ.
-
What industry is Novartis (Tekturna) in?
Novartis (Tekturna)’s primary industry is Buildings and Property.
-
Is Novartis (Tekturna) a private or public company?
Novartis (Tekturna) is a Private company.
-
What is Novartis (Tekturna)’s current revenue?
The current revenue for Novartis (Tekturna) is .
-
Who are Novartis (Tekturna)’s investors?
Novartis has invested in Novartis (Tekturna).
-
When was Novartis (Tekturna) acquired?
Novartis (Tekturna) was acquired on 06-Jul-2016.
-
Who acquired Novartis (Tekturna)?
Novartis (Tekturna) was acquired by Noden Pharma and PDL BioPharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process